Problems in interpreting cost effectiveness in clinical trials. Experimental versus implementation costs
- PMID: 8306003
Problems in interpreting cost effectiveness in clinical trials. Experimental versus implementation costs
Abstract
Objective: To demonstrate the difficulty of estimating cost effectiveness of alternative implementation strategies using clinical trial data.
Design: Two examples drawn from a hearing-aid intervention trial and a physical-therapy trial for frail elderly are used to demonstrate how alternative implementation strategies may affect cost effectiveness. Sensitivity analysis is used to document a range of possible economic outcomes for each example and show how assumptions based on trials may bias implementation decisions.
Main outcome measures: Costs and cost-effectiveness ratios are estimated for alternative implementation strategies and compared with trial results.
Main results: Staffing and equipment substitutions, reconfigurations, and economies of scale can reduce the cost of trial interventions substantially. Such resource alterations as well as protocol and target group modifications may also have an impact on effectiveness. In both examples effectiveness can be reduced by as much as 50% and under certain conditions alternative implementation strategies will still be cost effective.
Conclusions: Cost effectiveness of implementations can differ substantially from a trial when different resources or target populations are incorporated. Institutions must conduct preimplementation studies which consider alternative resource configurations before adopting an intervention based on trial results.
Similar articles
-
Design and analysis issues for economic analysis alongside clinical trials.Med Care. 2009 Jul;47(7 Suppl 1):S14-20. doi: 10.1097/MLR.0b013e3181a31971. Med Care. 2009. PMID: 19536012 Review.
-
Cost-effectiveness as an outcome in randomized clinical trials.Clin Trials. 2006;3(6):543-51. doi: 10.1177/1740774506073105. Clin Trials. 2006. PMID: 17170039 Review.
-
The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.Ophthalmology. 2009 May;116(5):823-32. doi: 10.1016/j.ophtha.2008.12.056. Epub 2009 Mar 14. Ophthalmology. 2009. PMID: 19285730
-
Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.J Am Coll Cardiol. 2006 Jul 18;48(2):253-61. doi: 10.1016/j.jacc.2006.02.063. Epub 2006 Jun 22. J Am Coll Cardiol. 2006. PMID: 16843171
-
Procedures and methods of benefit assessments for medicines in Germany.Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5. Eur J Health Econ. 2008. PMID: 18987905
Cited by
-
A strategy for collecting pharmacoeconomic data during phase II/III clinical trials.Pharmacoeconomics. 1996 Mar;9(3):264-77. doi: 10.2165/00019053-199609030-00007. Pharmacoeconomics. 1996. PMID: 10160101
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical